%0 Journal Article
%T Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
%A Takeshi Inoue
%A Satoshi Anai
%A Sayuri Onishi
%A Makito Miyake
%A Nobumichi Tanaka
%A Akihide Hirayama
%A Kiyohide Fujimoto
%A Yoshihiko Hirao
%J BMC Urology
%D 2013
%I BioMed Central
%R 10.1186/1471-2490-13-1
%X LNCaP-COX-2 and LNCaP-Neo cells were treated with 0 to 1000 ¦ÌM diclofenac. Next, a clonogenic assay was performed in which cells were subjected to irradiation (0 to 4 Gy) with or without diclofenac. COX-2 expression and other relevant molecules were measured by real-time PCR and immunohistochemistry after irradiation and diclofenac treatment. In addition, we assessed the tumor volumes of xenograft LNCaP-COX-2 cells treated with topical diclofenac with or without radiation therapy (RT).LNCaP-COX-2 and LNCaP-Neo cell lines experienced cytotoxic effects of diclofenac in a dose related manner. Clonogenic assays demonstrated that LNCaP-COX-2 cells were significantly more resistant to RT than LNCaP-Neo cells. Furthermore, the addition of diclofenac sensitized LNCaP-COX-2 not but LNCaP-Neo cells to the cytocidal effects of radiation. In LNCaP-COX-2 cells, diclofenac enhanced radiation-induced apoptosis compared with RT alone. This phenomenon might be attributed to enhancement of RT-induced TRAIL expression as demonstrated by real-time PCR analysis. Lastly, tumor volumes of LNCaP-COX-2 cells xenograft treated with diclofenac or RT alone was >4-fold higher than in mice treated with combined diclofenac and radiation (p<0.05).These in vitro and in vivo findings suggest that conventional COX inhibitor, diclofenac enhances the effect of RT on prostate cancer cells that express COX-2. Thus, diclofenac may have potential as radiosensitizer for treatment of prostate cancer.Cyclooxygenase (COX; prostaglandin G/H synthase, EC 1.14.99.1) is a key enzyme that catalyzes the conversion of arachidonic acid to prostaglandins (PGs) and other prostanoids.Two isoforms of COX have been identified, COX-1 and COX-2 [1]. Recently, a splicing variant of COX-1 was identified. Alternative splicing generates four different mRNA variants derived from the COX-1 gene - COX-1, COX-3, and two partial COX-1s (PCOX-1 proteins). COX-3 and one of the PCOX-1 proteins (PCOX-1a) are made from the COX-1 gene but
%K Prostate cancer
%K Radiation therapy
%K COX-2
%K TRAIL
%K Apoptosis
%K Topical therapy
%K Radiosensitizer
%K Diclofenac
%K Radioresistance
%U http://www.biomedcentral.com/1471-2490/13/1